-
1
-
-
65449182650
-
Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy - morbidity and outcome results
-
Aaltomaa S.H., Kataja V.V., Lahtinen T., et al. Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy - morbidity and outcome results. Radiother Oncol 91 (2009) 213-216
-
(2009)
Radiother Oncol
, vol.91
, pp. 213-216
-
-
Aaltomaa, S.H.1
Kataja, V.V.2
Lahtinen, T.3
-
2
-
-
70350515452
-
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
-
Aizer A.A., Yu J.B., Colberg J.W., et al. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 93 (2009) 185-191
-
(2009)
Radiother Oncol
, vol.93
, pp. 185-191
-
-
Aizer, A.A.1
Yu, J.B.2
Colberg, J.W.3
-
3
-
-
77953961546
-
Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial
-
Al Mamgani A., Heemsbergen W.D., Levendag P.C., et al. Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial. Radiother Oncol 96 (2010) 13-18
-
(2010)
Radiother Oncol
, vol.96
, pp. 13-18
-
-
Al Mamgani, A.1
Heemsbergen, W.D.2
Levendag, P.C.3
-
4
-
-
17844402699
-
20-year outcomes following conservative management of clinically localized prostate cancer
-
Albertsen P.C., Hanley J.A., and Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095-2101
-
(2005)
JAMA
, vol.293
, pp. 2095-2101
-
-
Albertsen, P.C.1
Hanley, J.A.2
Fine, J.3
-
5
-
-
70350746418
-
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
-
Alongi F., Fiorino C., Cozzarini C., et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 93 (2009) 207-212
-
(2009)
Radiother Oncol
, vol.93
, pp. 207-212
-
-
Alongi, F.1
Fiorino, C.2
Cozzarini, C.3
-
6
-
-
65249083866
-
Quasi-IMAT technique and secondary cancer risk in prostate cancer
-
Alvarez M.J., Koelbl O., and Bogner L. Quasi-IMAT technique and secondary cancer risk in prostate cancer. Strahlenther Onkol 185 (2009) 248-253
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 248-253
-
-
Alvarez, M.J.1
Koelbl, O.2
Bogner, L.3
-
7
-
-
77953961599
-
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
-
10.1016/j.ijrobp.2009.07.1691
-
Arcangeli G., Saracino B., Gomellini S., et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys (2010) 10.1016/j.ijrobp.2009.07.1691
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Arcangeli, G.1
Saracino, B.2
Gomellini, S.3
-
8
-
-
77952881607
-
Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated vs conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
-
[Abstract]
-
Baumann M., Herrmann T., Koch R., et al. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated vs conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). EJC S7 (2009) 4 [Abstract]
-
(2009)
EJC
, vol.S7
, pp. 4
-
-
Baumann, M.1
Herrmann, T.2
Koch, R.3
-
9
-
-
45849089879
-
Exploring the role of cancer stem cells in radioresistance
-
Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 545-554
-
-
Baumann, M.1
Krause, M.2
Hill, R.3
-
11
-
-
0027985135
-
Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice
-
Baumann M., Liertz C., Baisch H., et al. Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother Oncol 32 (1994) 137-143
-
(1994)
Radiother Oncol
, vol.32
, pp. 137-143
-
-
Baumann, M.1
Liertz, C.2
Baisch, H.3
-
12
-
-
0032978937
-
Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation
-
Baumann M., Petersen C., Schulz P., et al. Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation. Radiother Oncol 50 (1999) 107-111
-
(1999)
Radiother Oncol
, vol.50
, pp. 107-111
-
-
Baumann, M.1
Petersen, C.2
Schulz, P.3
-
13
-
-
0026059042
-
Should tumors be clamped in radiobiological fractionation experiments?
-
Beck-Bornholdt H.P. Should tumors be clamped in radiobiological fractionation experiments?. Int J Radiat Oncol Biol Phys 21 (1991) 675-682
-
(1991)
Int J Radiat Oncol Biol Phys
, vol.21
, pp. 675-682
-
-
Beck-Bornholdt, H.P.1
-
14
-
-
0026013349
-
Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation
-
Beck-Bornholdt H.P., Omniczynski M., Theis E., et al. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncol 30 (1991) 57-63
-
(1991)
Acta Oncol
, vol.30
, pp. 57-63
-
-
Beck-Bornholdt, H.P.1
Omniczynski, M.2
Theis, E.3
-
15
-
-
23244463067
-
The alpha/beta ratio for prostate cancer: what is it, really?
-
Bentzen S.M., and Ritter M.A. The alpha/beta ratio for prostate cancer: what is it, really?. Radiother Oncol 76 (2005) 1-3
-
(2005)
Radiother Oncol
, vol.76
, pp. 1-3
-
-
Bentzen, S.M.1
Ritter, M.A.2
-
16
-
-
51049104630
-
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial
-
Bill-Axelson A., Holmberg L., Filen F., et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 100 (2008) 1144-1154
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1144-1154
-
-
Bill-Axelson, A.1
Holmberg, L.2
Filen, F.3
-
17
-
-
67149125847
-
Duration of androgen suppression in the treatment of prostate cancer
-
Bolla M., de Reijke T.M., Van Tienhoven G., et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 360 (2009) 2516-2527
-
(2009)
N Engl J Med
, vol.360
, pp. 2516-2527
-
-
Bolla, M.1
de Reijke, T.M.2
Van Tienhoven, G.3
-
18
-
-
0030856678
-
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
-
Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
-
(1997)
N Engl J Med
, vol.337
, pp. 295-300
-
-
Bolla, M.1
Gonzalez, D.2
Warde, P.3
-
19
-
-
23744493443
-
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
-
Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
-
(2005)
Lancet
, vol.366
, pp. 572-578
-
-
Bolla, M.1
van Poppel, H.2
Collette, L.3
-
20
-
-
33747881607
-
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
-
Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
-
(2006)
Lancet
, vol.368
, pp. 843-854
-
-
Bourhis, J.1
Overgaard, J.2
Audry, H.3
-
21
-
-
7444265874
-
Fractionation and late rectal toxicity
-
Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1013-1015
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 1013-1015
-
-
Brenner, D.J.1
-
22
-
-
0032913909
-
Fractionation and protraction for radiotherapy of prostate carcinoma
-
Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.43
, pp. 1095-1101
-
-
Brenner, D.J.1
Hall, E.J.2
-
23
-
-
0036140325
-
Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue
-
Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 6-13
-
-
Brenner, D.J.1
Martinez, A.A.2
Edmundson, G.K.3
-
24
-
-
39749114978
-
Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability
-
Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8 (2008) 180-192
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 180-192
-
-
Bristow, R.G.1
Hill, R.P.2
-
25
-
-
34250343422
-
Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies
-
Bristow R.G., Ozcelik H., Jalali F., et al. Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies. Radiother Oncol 83 (2007) 220-230
-
(2007)
Radiother Oncol
, vol.83
, pp. 220-230
-
-
Bristow, R.G.1
Ozcelik, H.2
Jalali, F.3
-
26
-
-
70350492288
-
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: implications for the assessment of the optimal correction strategies
-
Broggi S., Cozzarini C., Fiorino C., et al. Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: implications for the assessment of the optimal correction strategies. Radiother Oncol 93 (2009) 246-252
-
(2009)
Radiother Oncol
, vol.93
, pp. 246-252
-
-
Broggi, S.1
Cozzarini, C.2
Fiorino, C.3
-
27
-
-
33646007333
-
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance
-
Carnell D.M., Smith R.E., Daley F.M., et al. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance. Int J Radiat Oncol Biol Phys 65 (2006) 91-99
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 91-99
-
-
Carnell, D.M.1
Smith, R.E.2
Daley, F.M.3
-
28
-
-
67649544143
-
Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity
-
Coote J.H., Wylie J.P., Cowan R.A., et al. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity. Int J Radiat Oncol Biol Phys 74 (2009) 1121-1127
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 1121-1127
-
-
Coote, J.H.1
Wylie, J.P.2
Cowan, R.A.3
-
29
-
-
45849086912
-
Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study
-
Cozzarini C., Fiorino C., Di Muzio N., et al. Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study. Radiother Oncol 88 (2008) 26-33
-
(2008)
Radiother Oncol
, vol.88
, pp. 26-33
-
-
Cozzarini, C.1
Fiorino, C.2
Di Muzio, N.3
-
30
-
-
56349144290
-
Does treatment duration affect outcome after radiotherapy for prostate cancer?
-
D'Ambrosio D.J., Li T., Horwitz E.M., et al. Does treatment duration affect outcome after radiotherapy for prostate cancer?. Int J Radiat Oncol Biol Phys 72 (2008) 1402-1407
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 1402-1407
-
-
D'Ambrosio, D.J.1
Li, T.2
Horwitz, E.M.3
-
31
-
-
0037099725
-
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
-
D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95 (2002) 281-286
-
(2002)
Cancer
, vol.95
, pp. 281-286
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
-
32
-
-
34248594934
-
Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?
-
Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?. Clin Oncol (R Coll Radiol) 19 (2007) 289-301
-
(2007)
Clin Oncol (R Coll Radiol)
, vol.19
, pp. 289-301
-
-
Dasu, A.1
-
33
-
-
20144373530
-
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
-
Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
-
(2005)
Br J Cancer
, vol.92
, pp. 488-498
-
-
Dearnaley, D.P.1
Hall, E.2
Lawrence, D.3
-
34
-
-
34249316816
-
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
-
Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
-
(2007)
Lancet Oncol
, vol.8
, pp. 475-487
-
-
Dearnaley, D.P.1
Sydes, M.R.2
Graham, J.D.3
-
35
-
-
77953958629
-
Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer
-
Delouya G., Carrier J.F., Beliveau-Nadeau D., et al. Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer. Radiother Oncol 96 (2010) 43-47
-
(2010)
Radiother Oncol
, vol.96
, pp. 43-47
-
-
Delouya, G.1
Carrier, J.F.2
Beliveau-Nadeau, D.3
-
36
-
-
67349148564
-
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer
-
Denham J.W., Kumar M., Gleeson P.S., et al. Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys 74 (2009) 404-411
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 404-411
-
-
Denham, J.W.1
Kumar, M.2
Gleeson, P.S.3
-
37
-
-
54349113978
-
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial
-
Denham J.W., Steigler A., Wilcox C., et al. Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial. Lancet Oncol 9 (2008) 1058-1068
-
(2008)
Lancet Oncol
, vol.9
, pp. 1058-1068
-
-
Denham, J.W.1
Steigler, A.2
Wilcox, C.3
-
38
-
-
70349280706
-
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?
-
Denham J.W., Steigler A., Wilcox C., et al. Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?. Cancer 115 (2009) 4477-4487
-
(2009)
Cancer
, vol.115
, pp. 4477-4487
-
-
Denham, J.W.1
Steigler, A.2
Wilcox, C.3
-
39
-
-
67349135763
-
Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer
-
Di Muzio N., Fiorino C., Cozzarini C., et al. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 74 (2009) 392-398
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 392-398
-
-
Di Muzio, N.1
Fiorino, C.2
Cozzarini, C.3
-
40
-
-
77951644675
-
Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy
-
Dolezel M., Odrazka K., Vaculikova M., et al. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy. Strahlenther Onkol 186 (2010) 197-202
-
(2010)
Strahlenther Onkol
, vol.186
, pp. 197-202
-
-
Dolezel, M.1
Odrazka, K.2
Vaculikova, M.3
-
41
-
-
0033026882
-
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
-
Duchesne G.M., and Peters L.J. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 44 (1999) 747-748
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 747-748
-
-
Duchesne, G.M.1
Peters, L.J.2
-
42
-
-
45849116936
-
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk
-
Fenoglietto P., Laliberte B., Allaw A., et al. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiother Oncol 88 (2008) 77-87
-
(2008)
Radiother Oncol
, vol.88
, pp. 77-87
-
-
Fenoglietto, P.1
Laliberte, B.2
Allaw, A.3
-
43
-
-
21344432775
-
The radiobiology of prostate cancer including new aspects of fractionated radiotherapy
-
Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44 (2005) 265-276
-
(2005)
Acta Oncol
, vol.44
, pp. 265-276
-
-
Fowler, J.F.1
-
44
-
-
0042383102
-
How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203
-
Fowler J.F., Ritter M.A., Fenwick J.D., et al. How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203. Int J Radiat Oncol Biol Phys 57 (2003) 593-595
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 593-595
-
-
Fowler, J.F.1
Ritter, M.A.2
Fenwick, J.D.3
-
45
-
-
70449767181
-
Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer
-
Ghadjar P., Gwerder N., Madlung A., et al. Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlenther Onkol 185 (2009) 731-735
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 731-735
-
-
Ghadjar, P.1
Gwerder, N.2
Madlung, A.3
-
46
-
-
65449155429
-
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer
-
Ghadjar P., Matzinger O., Isaak B., et al. Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Radiother Oncol 91 (2009) 237-242
-
(2009)
Radiother Oncol
, vol.91
, pp. 237-242
-
-
Ghadjar, P.1
Matzinger, O.2
Isaak, B.3
-
47
-
-
70449752075
-
A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy
-
Hermesse J., Biver S., Jansen N., et al. A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlenther Onkol 185 (2009) 736-742
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 736-742
-
-
Hermesse, J.1
Biver, S.2
Jansen, N.3
-
48
-
-
14644414177
-
Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation
-
Herrmann T., and Baumann M. Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 181 (2005) 65-76
-
(2005)
Strahlenther Onkol
, vol.181
, pp. 65-76
-
-
Herrmann, T.1
Baumann, M.2
-
49
-
-
12344337748
-
Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation
-
Hessel F., Krause M., Helm A., et al. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation. Int J Radiat Biol 80 (2004) 719-727
-
(2004)
Int J Radiat Biol
, vol.80
, pp. 719-727
-
-
Hessel, F.1
Krause, M.2
Helm, A.3
-
50
-
-
0942300639
-
Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice
-
Hessel F., Krause M., Petersen C., et al. Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice. Int J Radiat Oncol Biol Phys 58 (2004) 510-518
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 510-518
-
-
Hessel, F.1
Krause, M.2
Petersen, C.3
-
51
-
-
0142178066
-
Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice
-
Hessel F., Petersen C., Zips D., et al. Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice. Int J Radiat Biol 79 (2003) 479-486
-
(2003)
Int J Radiat Biol
, vol.79
, pp. 479-486
-
-
Hessel, F.1
Petersen, C.2
Zips, D.3
-
52
-
-
34248549839
-
Hypofractionation in clinical trials for prostate cancer
-
Hoskin P.J., and Dearnaley D.P. Hypofractionation in clinical trials for prostate cancer. Clin Oncol (R Coll Radiol) 19 (2007) 287-288
-
(2007)
Clin Oncol (R Coll Radiol)
, vol.19
, pp. 287-288
-
-
Hoskin, P.J.1
Dearnaley, D.P.2
-
53
-
-
46049115879
-
Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours
-
Iori M., Cattaneo G.M., Cagni E., et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol 88 (2008) 34-45
-
(2008)
Radiother Oncol
, vol.88
, pp. 34-45
-
-
Iori, M.1
Cattaneo, G.M.2
Cagni, E.3
-
54
-
-
70349324507
-
Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer
-
Jereczek-Fossa B.A., Fariselli L., Beltramo G., et al. Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiother Oncol 93 (2009) 14-17
-
(2009)
Radiother Oncol
, vol.93
, pp. 14-17
-
-
Jereczek-Fossa, B.A.1
Fariselli, L.2
Beltramo, G.3
-
55
-
-
34548142975
-
Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer
-
Jereczek-Fossa B.A., and Orecchia R. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. Radiother Oncol 84 (2007) 197-215
-
(2007)
Radiother Oncol
, vol.84
, pp. 197-215
-
-
Jereczek-Fossa, B.A.1
Orecchia, R.2
-
56
-
-
77951293327
-
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: Nonrandomized comparison with conventional fractionation
-
in press
-
Jereczek-Fossa BA, Zerini D, Fodor C, et al. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation. Urol Oncol 2010; in press.
-
Urol Oncol
, pp. 2010
-
-
Jereczek-Fossa, B.A.1
Zerini, D.2
Fodor, C.3
-
57
-
-
34548548576
-
Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
-
Junius S., Haustermans K., Bussels B., et al. Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study. Radiat Oncol 2 (2007) 29
-
(2007)
Radiat Oncol
, vol.2
, pp. 29
-
-
Junius, S.1
Haustermans, K.2
Bussels, B.3
-
58
-
-
0142186650
-
How low is the alpha/beta ratio for prostate cancer?
-
Kal H.B., and Van Gellekom M.P. How low is the alpha/beta ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 57 (2003) 1116-1121
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 1116-1121
-
-
Kal, H.B.1
Van Gellekom, M.P.2
-
59
-
-
65249186370
-
Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy
-
Kalz J., Sterzing F., Schubert K., et al. Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy. Strahlenther Onkol 185 (2009) 241-247
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 241-247
-
-
Kalz, J.1
Sterzing, F.2
Schubert, K.3
-
60
-
-
70350688146
-
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
-
Karlsdottir A., Muren L.P., Wentzel-Larsen T., et al. Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. Acta Oncol 48 (2009) 874-881
-
(2009)
Acta Oncol
, vol.48
, pp. 874-881
-
-
Karlsdottir, A.1
Muren, L.P.2
Wentzel-Larsen, T.3
-
61
-
-
77749338092
-
Stereotactic body radiotherapy for organ-confined prostate cancer
-
Katz A.J., Santoro M., Ashley R., et al. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 10 (2010) 1
-
(2010)
BMC Urol
, vol.10
, pp. 1
-
-
Katz, A.J.1
Santoro, M.2
Ashley, R.3
-
62
-
-
45849093738
-
Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans
-
Kim Y., and Tome W.A. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans. Acta Oncol 47 (2008) 906-916
-
(2008)
Acta Oncol
, vol.47
, pp. 906-916
-
-
Kim, Y.1
Tome, W.A.2
-
63
-
-
61349144278
-
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
-
King C.R., Brooks J.D., Gill H., et al. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73 (2009) 1043-1048
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 1043-1048
-
-
King, C.R.1
Brooks, J.D.2
Gill, H.3
-
64
-
-
73949130115
-
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
-
Klotz L., Zhang L., Lam A., et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28 (2010) 126-131
-
(2010)
J Clin Oncol
, vol.28
, pp. 126-131
-
-
Klotz, L.1
Zhang, L.2
Lam, A.3
-
65
-
-
0033921106
-
Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor
-
Koppie T.M., Grossfeld G.D., Miller D., et al. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor. J Urol 164 (2000) 81-88
-
(2000)
J Urol
, vol.164
, pp. 81-88
-
-
Koppie, T.M.1
Grossfeld, G.D.2
Miller, D.3
-
66
-
-
77249134524
-
The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide
-
Korreman S., Rasch C., McNair H., et al. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother Oncol 94 (2010) 129-144
-
(2010)
Radiother Oncol
, vol.94
, pp. 129-144
-
-
Korreman, S.1
Rasch, C.2
McNair, H.3
-
67
-
-
77953120925
-
Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics
-
Krakowsky Y., Loblaw A., and Klotz L. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics. J Urol 184 (2010) 131-135
-
(2010)
J Urol
, vol.184
, pp. 131-135
-
-
Krakowsky, Y.1
Loblaw, A.2
Klotz, L.3
-
68
-
-
77953958105
-
Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers
-
Kron T., Thomas J., Fox C., et al. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiother Oncol 95 (2010) 191-197
-
(2010)
Radiother Oncol
, vol.95
, pp. 191-197
-
-
Kron, T.1
Thomas, J.2
Fox, C.3
-
69
-
-
37049023209
-
Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer
-
Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.70
, pp. 67-74
-
-
Kuban, D.A.1
Tucker, S.L.2
Dong, L.3
-
70
-
-
19944431984
-
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995
-
Kupelian P., Kuban D., Thames H., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 415-419
-
-
Kupelian, P.1
Kuban, D.2
Thames, H.3
-
71
-
-
41749108426
-
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer
-
Kupelian P.A., Ciezki J., Reddy C.A., et al. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 16-22
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 16-22
-
-
Kupelian, P.A.1
Ciezki, J.2
Reddy, C.A.3
-
72
-
-
0025184798
-
Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity
-
Lai P.P., Perez C.A., Shapiro S.J., et al. Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int J Radiat Oncol Biol Phys 19 (1990) 561-568
-
(1990)
Int J Radiat Oncol Biol Phys
, vol.19
, pp. 561-568
-
-
Lai, P.P.1
Perez, C.A.2
Shapiro, S.J.3
-
73
-
-
0025942528
-
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience
-
Lai P.P., Pilepich M.V., Krall J.M., et al. The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. Int J Radiat Oncol Biol Phys 21 (1991) 925-933
-
(1991)
Int J Radiat Oncol Biol Phys
, vol.21
, pp. 925-933
-
-
Lai, P.P.1
Pilepich, M.V.2
Krall, J.M.3
-
74
-
-
49549097170
-
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results
-
Lim T.S., Cheung P.C., Loblaw D.A., et al. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results. Int J Radiat Oncol Biol Phys 72 (2008) 85-92
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 85-92
-
-
Lim, T.S.1
Cheung, P.C.2
Loblaw, D.A.3
-
75
-
-
70349140531
-
Outcomes of localized prostate cancer following conservative management
-
Lu-Yao G.L., Albertsen P.C., Moore D.F., et al. Outcomes of localized prostate cancer following conservative management. JAMA 302 (2009) 1202-1209
-
(2009)
JAMA
, vol.302
, pp. 1202-1209
-
-
Lu-Yao, G.L.1
Albertsen, P.C.2
Moore, D.F.3
-
76
-
-
33847248003
-
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results
-
Madsen B.L., Hsi R.A., Pham H.T., et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67 (2007) 1099-1105
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 1099-1105
-
-
Madsen, B.L.1
Hsi, R.A.2
Pham, H.T.3
-
77
-
-
35448944905
-
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
-
Martin J.M., Rosewall T., Bayley A., et al. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 69 (2007) 1084-1089
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 1084-1089
-
-
Martin, J.M.1
Rosewall, T.2
Bayley, A.3
-
78
-
-
69449102350
-
Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer
-
Marzi S., Saracino B., Petrongari M.G., et al. Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer. J Exp Clin Cancer Res 28 (2009) 117
-
(2009)
J Exp Clin Cancer Res
, vol.28
, pp. 117
-
-
Marzi, S.1
Saracino, B.2
Petrongari, M.G.3
-
80
-
-
28444478320
-
Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells
-
Meng A.X., Jalali F., Cuddihy A., et al. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol 76 (2005) 168-176
-
(2005)
Radiother Oncol
, vol.76
, pp. 168-176
-
-
Meng, A.X.1
Jalali, F.2
Cuddihy, A.3
-
81
-
-
34347390760
-
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response
-
Milosevic M., Chung P., Parker C., et al. Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response. Cancer Res 67 (2007) 6022-6025
-
(2007)
Cancer Res
, vol.67
, pp. 6022-6025
-
-
Milosevic, M.1
Chung, P.2
Parker, C.3
-
82
-
-
45849137509
-
Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis
-
Morgan S.C., Waldron T.S., Eapen L., et al. Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis. Radiother Oncol 88 (2008) 1-9
-
(2008)
Radiother Oncol
, vol.88
, pp. 1-9
-
-
Morgan, S.C.1
Waldron, T.S.2
Eapen, L.3
-
83
-
-
77953956154
-
Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years
-
Munro N.P., Al Qaisieh B., Bownes P., et al. Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years. Radiother Oncol 96 (2010) 34-37
-
(2010)
Radiother Oncol
, vol.96
, pp. 34-37
-
-
Munro, N.P.1
Al Qaisieh, B.2
Bownes, P.3
-
84
-
-
58149171936
-
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients
-
Nairz O., Merz F., Deutschmann H., et al. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol 184 (2008) 663-667
-
(2008)
Strahlenther Onkol
, vol.184
, pp. 663-667
-
-
Nairz, O.1
Merz, F.2
Deutschmann, H.3
-
85
-
-
54949133297
-
Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials
-
Nanda A., and D'Amico A.V. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials. BJU Int 102 (2008) 1366-1368
-
(2008)
BJU Int
, vol.102
, pp. 1366-1368
-
-
Nanda, A.1
D'Amico, A.V.2
-
86
-
-
45849098368
-
Novel prostate brachytherapy technique: improved dosimetric and clinical outcome
-
Nobes J.P., Khaksar S.J., Hawkins M.A., et al. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome. Radiother Oncol 88 (2008) 121-126
-
(2008)
Radiother Oncol
, vol.88
, pp. 121-126
-
-
Nobes, J.P.1
Khaksar, S.J.2
Hawkins, M.A.3
-
87
-
-
70449884170
-
A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma: a report on acute toxicity
-
Norkus D., Miller A., Kurtinaitis J., et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma: a report on acute toxicity. Strahlenther Onkol 185 (2009) 715-721
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 715-721
-
-
Norkus, D.1
Miller, A.2
Kurtinaitis, J.3
-
88
-
-
0742323730
-
Active surveillance: towards a new paradigm in the management of early prostate cancer
-
Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 5 (2004) 101-106
-
(2004)
Lancet Oncol
, vol.5
, pp. 101-106
-
-
Parker, C.1
-
89
-
-
10744221495
-
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
-
Parker C., Milosevic M., Toi A., et al. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 750-757
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 750-757
-
-
Parker, C.1
Milosevic, M.2
Toi, A.3
-
90
-
-
54049158994
-
Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review
-
Pasquier D., and Ballereau C. Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 72 (2008) 972-979
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 972-979
-
-
Pasquier, D.1
Ballereau, C.2
-
91
-
-
77950334934
-
How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons
-
Peeters A., Grutters J.P., Pijls-Johannesma M., et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol 95 (2010) 45-53
-
(2010)
Radiother Oncol
, vol.95
, pp. 45-53
-
-
Peeters, A.1
Grutters, J.P.2
Pijls-Johannesma, M.3
-
92
-
-
14844302686
-
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy
-
Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 1019-1034
-
-
Peeters, S.T.1
Heemsbergen, W.D.2
van Putten, W.L.3
-
93
-
-
33644516600
-
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
-
Peeters S.T.H., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 1151-1161
-
-
Peeters, S.T.H.1
Lebesque, J.V.2
Heemsbergen, W.D.3
-
94
-
-
33646462895
-
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
-
Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
-
(2006)
J Clin Oncol
, vol.24
, pp. 1990-1996
-
-
Peeters, S.T.H.1
Heemsbergen, W.D.2
Koper, P.C.M.3
-
95
-
-
0035479092
-
Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation
-
Petersen C., Zips D., Krause M., et al. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys 51 (2001) 483-493
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.51
, pp. 483-493
-
-
Petersen, C.1
Zips, D.2
Krause, M.3
-
96
-
-
70350499495
-
Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review
-
Pieters B.R., de Back D.Z., Koning C.C., et al. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol 93 (2009) 168-173
-
(2009)
Radiother Oncol
, vol.93
, pp. 168-173
-
-
Pieters, B.R.1
de Back, D.Z.2
Koning, C.C.3
-
97
-
-
45849132052
-
Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy
-
Pieters B.R., van de Kamer J.B., van Herten Y.R., et al. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. Radiother Oncol 88 (2008) 46-52
-
(2008)
Radiother Oncol
, vol.88
, pp. 46-52
-
-
Pieters, B.R.1
van de Kamer, J.B.2
van Herten, Y.R.3
-
98
-
-
70350495178
-
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost
-
Pinkawa M., Attieh C., Piroth M.D., et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost. Radiother Oncol 93 (2009) 213-219
-
(2009)
Radiother Oncol
, vol.93
, pp. 213-219
-
-
Pinkawa, M.1
Attieh, C.2
Piroth, M.D.3
-
99
-
-
61349186930
-
Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis
-
Pinkawa M., Piroth M.D., Asadpour B., et al. Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis. Strahlenther Onkol 185 (2009) 101-108
-
(2009)
Strahlenther Onkol
, vol.185
, pp. 101-108
-
-
Pinkawa, M.1
Piroth, M.D.2
Asadpour, B.3
-
100
-
-
30544434287
-
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
-
Pollack A., Hanlon A.L., Horwitz E.M., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 64 (2006) 518-526
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 518-526
-
-
Pollack, A.1
Hanlon, A.L.2
Horwitz, E.M.3
-
101
-
-
0036680314
-
Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
-
Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
-
102
-
-
49749087577
-
Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer
-
Ritter M. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol 18 (2008) 249-256
-
(2008)
Semin Radiat Oncol
, vol.18
, pp. 249-256
-
-
Ritter, M.1
-
103
-
-
61449210091
-
Hypofractionation for prostate cancer
-
Ritter M., Forman J., Kupelian P., et al. Hypofractionation for prostate cancer. Cancer J 15 (2009) 1-6
-
(2009)
Cancer J
, vol.15
, pp. 1-6
-
-
Ritter, M.1
Forman, J.2
Kupelian, P.3
-
104
-
-
61349143046
-
Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses
-
Rosewall T., Kong V., Vesprini D., et al. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses. Radiother Oncol 90 (2009) 325-330
-
(2009)
Radiother Oncol
, vol.90
, pp. 325-330
-
-
Rosewall, T.1
Kong, V.2
Vesprini, D.3
-
105
-
-
51049114711
-
Optimal treatment margins for radiotherapy of prostate cancer based on interfraction imaging
-
Rothe A.M., Eilertsen K., and Malinen E. Optimal treatment margins for radiotherapy of prostate cancer based on interfraction imaging. Acta Oncol 47 (2008) 1373-1381
-
(2008)
Acta Oncol
, vol.47
, pp. 1373-1381
-
-
Rothe, A.M.1
Eilertsen, K.2
Malinen, E.3
-
106
-
-
38349158398
-
Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer
-
Sanguineti G., Endres E.J., Parker B.C., et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol 47 (2008) 301-310
-
(2008)
Acta Oncol
, vol.47
, pp. 301-310
-
-
Sanguineti, G.1
Endres, E.J.2
Parker, B.C.3
-
107
-
-
0030737527
-
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee
-
Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350 (1997) 161-165
-
(1997)
Lancet
, vol.350
, pp. 161-165
-
-
Saunders, M.1
Dische, S.2
Barrett, A.3
-
108
-
-
70350504880
-
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer
-
Seppala J., Seppanen M., Arponen E., et al. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. Radiother Oncol 93 (2009) 234-240
-
(2009)
Radiother Oncol
, vol.93
, pp. 234-240
-
-
Seppala, J.1
Seppanen, M.2
Arponen, E.3
-
109
-
-
38149120882
-
HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between
-
Seppenwoolde Y., Kolkman-Deurloo I.K., Sipkema D., et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between. Radiother Oncol 86 (2008) 114-119
-
(2008)
Radiother Oncol
, vol.86
, pp. 114-119
-
-
Seppenwoolde, Y.1
Kolkman-Deurloo, I.K.2
Sipkema, D.3
-
110
-
-
70349231253
-
Contemporary risk profile of prostate cancer in the United States
-
Shao Y.H., Demissie K., Shih W., et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 101 (2009) 1280-1283
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1280-1283
-
-
Shao, Y.H.1
Demissie, K.2
Shih, W.3
-
111
-
-
70349326442
-
Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy
-
Smeenk R.J., van Lin E.N., van Kollenburg P., et al. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiother Oncol 93 (2009) 131-136
-
(2009)
Radiother Oncol
, vol.93
, pp. 131-136
-
-
Smeenk, R.J.1
van Lin, E.N.2
van Kollenburg, P.3
-
112
-
-
33746994052
-
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity
-
Soete G., Arcangeli S., De Meerleer G., et al. Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother Oncol 80 (2006) 78-81
-
(2006)
Radiother Oncol
, vol.80
, pp. 78-81
-
-
Soete, G.1
Arcangeli, S.2
De Meerleer, G.3
-
113
-
-
38149088769
-
A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer
-
South C.P., Khoo V.S., Naismith O., et al. A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) 20 (2008) 15-21
-
(2008)
Clin Oncol (R Coll Radiol)
, vol.20
, pp. 15-21
-
-
South, C.P.1
Khoo, V.S.2
Naismith, O.3
-
114
-
-
38149079824
-
Helical tomotherapy. Experiences of the first 150 patients in Heidelberg
-
Sterzing F., Schubert K., Sroka-Perez G., et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 184 (2008) 8-14
-
(2008)
Strahlenther Onkol
, vol.184
, pp. 8-14
-
-
Sterzing, F.1
Schubert, K.2
Sroka-Perez, G.3
-
115
-
-
0017754557
-
3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval
-
3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval. Radiat Res 72 (1977) 440-454
-
(1977)
Radiat Res
, vol.72
, pp. 440-454
-
-
Suit, H.D.1
Howes, A.E.2
Hunter, N.3
-
116
-
-
45849091146
-
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies
-
Supiot S., Shubbar S., Fleshner N., et al. A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies. Radiother Oncol 88 (2008) 53-60
-
(2008)
Radiother Oncol
, vol.88
, pp. 53-60
-
-
Supiot, S.1
Shubbar, S.2
Fleshner, N.3
-
117
-
-
77953962354
-
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995
-
Thames H.D., Kuban D., Levy L.B., et al. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol 96 (2010) 6-12
-
(2010)
Radiother Oncol
, vol.96
, pp. 6-12
-
-
Thames, H.D.1
Kuban, D.2
Levy, L.B.3
-
118
-
-
0030586016
-
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism
-
Thames H.D., Ruifrok A.C., Milas L., et al. Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism. Int J Radiat Oncol Biol Phys 35 (1996) 951-962
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.35
, pp. 951-962
-
-
Thames, H.D.1
Ruifrok, A.C.2
Milas, L.3
-
119
-
-
59549095954
-
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial
-
Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181 (2009) 956-962
-
(2009)
J Urol
, vol.181
, pp. 956-962
-
-
Thompson, I.M.1
Tangen, C.M.2
Paradelo, J.3
-
120
-
-
78651469971
-
Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer
-
in press
-
Townsend NC, Huth BJ, Ding W, et al. Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer. Am J Clin Oncol 2010; in press.
-
Am J Clin Oncol
, pp. 2010
-
-
Townsend, N.C.1
Huth, B.J.2
Ding, W.3
-
121
-
-
0025786192
-
Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues
-
Trott K.R., and Kummermehr J. Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 22 (1991) 159-160
-
(1991)
Radiother Oncol
, vol.22
, pp. 159-160
-
-
Trott, K.R.1
Kummermehr, J.2
-
122
-
-
0033611522
-
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
-
Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
-
(1999)
N Engl J Med
, vol.340
, pp. 265-271
-
-
Turrisi, A.T.1
Kim, K.2
Blum, R.3
-
123
-
-
0031670132
-
Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?
-
Urano M., Nishimura Y., Kuroda M., et al. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?. Radiother Oncol 48 (1998) 221-228
-
(1998)
Radiother Oncol
, vol.48
, pp. 221-228
-
-
Urano, M.1
Nishimura, Y.2
Kuroda, M.3
-
124
-
-
0028965204
-
The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor
-
Urano M., Nishimura Y., and Yaes R. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor. Radiat Res 142 (1995) 204-211
-
(1995)
Radiat Res
, vol.142
, pp. 204-211
-
-
Urano, M.1
Nishimura, Y.2
Yaes, R.3
-
125
-
-
77749286517
-
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study
-
van den Bergh R.C., Vasarainen H., van der Poel H.G., et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int 105 (2010) 956-962
-
(2010)
BJU Int
, vol.105
, pp. 956-962
-
-
van den Bergh, R.C.1
Vasarainen, H.2
van der Poel, H.G.3
-
126
-
-
38149079931
-
Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods
-
van den Bosch M.R., Lips I.M., Lagerburg V., et al. Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods. Radiother Oncol 86 (2008) 120-125
-
(2008)
Radiother Oncol
, vol.86
, pp. 120-125
-
-
van den Bosch, M.R.1
Lips, I.M.2
Lagerburg, V.3
-
127
-
-
0002241541
-
Radiation response and tolerance of normal tissues
-
Steel G.G. (Ed), Arnold, London
-
van der Kogel A.J. Radiation response and tolerance of normal tissues. In: Steel G.G. (Ed). Basic clinical radiobiology (2002), Arnold, London 30-41
-
(2002)
Basic clinical radiobiology
, pp. 30-41
-
-
van der Kogel, A.J.1
-
128
-
-
61349134730
-
Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients
-
van Haaren P.M., Bel A., Hofman P., et al. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol 90 (2009) 291-298
-
(2009)
Radiother Oncol
, vol.90
, pp. 291-298
-
-
van Haaren, P.M.1
Bel, A.2
Hofman, P.3
-
129
-
-
45849116534
-
Dosimetric evaluation of prostate rotations and their correction by couch rotations
-
van Herten Y.R., van de Kamer J.B., van Wieringen N., et al. Dosimetric evaluation of prostate rotations and their correction by couch rotations. Radiother Oncol 88 (2008) 156-162
-
(2008)
Radiother Oncol
, vol.88
, pp. 156-162
-
-
van Herten, Y.R.1
van de Kamer, J.B.2
van Wieringen, N.3
-
130
-
-
70350502585
-
18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer
-
Wang H., Vees H., Miralbell R., et al. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. Radiother Oncol 93 (2009) 220-225
-
(2009)
Radiother Oncol
, vol.93
, pp. 220-225
-
-
Wang, H.1
Vees, H.2
Miralbell, R.3
-
132
-
-
0141576615
-
The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
-
Wang J.Z., Li X.A., Yu C.X., et al. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 57 (2003) 1101-1108
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 1101-1108
-
-
Wang, J.Z.1
Li, X.A.2
Yu, C.X.3
-
133
-
-
58649103315
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
-
Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373 (2009) 301-308
-
(2009)
Lancet
, vol.373
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
-
134
-
-
67649992725
-
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
-
Wiegel T., Bottke D., Steiner U., et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27 (2009) 2924-2930
-
(2009)
J Clin Oncol
, vol.27
, pp. 2924-2930
-
-
Wiegel, T.1
Bottke, D.2
Steiner, U.3
-
135
-
-
34247097886
-
Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer
-
Williams S.G., Taylor J.M., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 24-33
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.68
, pp. 24-33
-
-
Williams, S.G.1
Taylor, J.M.2
Liu, N.3
-
136
-
-
0021879466
-
Biologic basis for altered fractionation schemes
-
Withers H.R. Biologic basis for altered fractionation schemes. Cancer 55 (1985) 2086-2095
-
(1985)
Cancer
, vol.55
, pp. 2086-2095
-
-
Withers, H.R.1
-
137
-
-
0023894783
-
The hazard of accelerated tumor clonogen repopulation during radiotherapy
-
Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
-
(1988)
Acta Oncol
, vol.27
, pp. 131-146
-
-
Withers, H.R.1
Taylor, J.M.2
Maciejewski, B.3
-
138
-
-
70350502597
-
Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer
-
Wolff D., Stieler F., Welzel G., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93 (2009) 226-233
-
(2009)
Radiother Oncol
, vol.93
, pp. 226-233
-
-
Wolff, D.1
Stieler, F.2
Welzel, G.3
-
139
-
-
41749122843
-
Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer
-
Yassa M., Fortin B., Fortin M.A., et al. Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 58-63
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 58-63
-
-
Yassa, M.1
Fortin, B.2
Fortin, M.A.3
-
140
-
-
33750297651
-
Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial
-
Yeoh E.E., Holloway R.H., Fraser R.J., et al. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. Int J Radiat Oncol Biol Phys 66 (2006) 1072-1083
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 1072-1083
-
-
Yeoh, E.E.1
Holloway, R.H.2
Fraser, R.J.3
-
141
-
-
0036680294
-
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
-
Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 1111-1116
-
-
Zelefsky, M.J.1
Fuks, Z.2
Hunt, M.3
-
142
-
-
24644443217
-
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial
-
Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
-
(2005)
JAMA
, vol.294
, pp. 1233-1239
-
-
Zietman, A.L.1
DeSilvio, M.L.2
Slater, J.D.3
-
143
-
-
77949509341
-
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton Radiation Oncology Group/American College of Radiology 95-09
-
Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton Radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 28 (2010) 1106-1111
-
(2010)
J Clin Oncol
, vol.28
, pp. 1106-1111
-
-
Zietman, A.L.1
Bae, K.2
Slater, J.D.3
-
144
-
-
77953240192
-
Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity
-
Zilli T., Rouzaud M., Jorcano S., et al. Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity. Technol Cancer Res Treat 9 (2010) 263-270
-
(2010)
Technol Cancer Res Treat
, vol.9
, pp. 263-270
-
-
Zilli, T.1
Rouzaud, M.2
Jorcano, S.3
|